China’s property sector is on shaky grounds but one company says its books are clean
CCCG Real Estate is one of China’s biggest residential property developers and has stated it can pay its upcoming dues. Can the company be believed?
Business & Technology
Chinese companies going global. Global companies capitalizing on the size and growth of the China market. State-owned enterprises. Policy-based state investment. Startup unicorns with Chinese characteristics. There is no shortage of business stories to tell in China.
More Posts
Fertilizer prices are going through the roof
War and pestilence are constricting the world’s supply of fertilizers, making profits for Chinese companies but threatening tough times ahead.
Can China’s cement industry be cleaned up?
China produces almost 60% of the world’s cement and accounts for most of the colossal carbon footprint of the industry. Plans and new technology are afoot to clean up cement, but it might prove to be largely impossible.
Car sales tanked last month, but CATL and BYD can’t get enough lithium
CATL and BYD are dominant players in China’s electric vehicle and battery industries, but their success depends on careful supply chain management and continued access to lithium, most of which does not come from China.
Q&A: Veteran analyst Rui Ma on Beijing’s tech crackdown and common misconceptions about China’s tech sector
Rui Ma, founder of Tech Buzz China, talks about the current state of the Chinese tech sector and common misconceptions about Chinese tech companies.
Connecting the U.S. and China through entrepreneurship with Jeff Ji and Ken Wong
Entrepreneurs Jeff Ji and Ken Wong have used cultural activities such as Harley-Davidson motorcycle tours and badminton to bring people from the U.S. and China together.
Fixed income investments in China — A-Share Intelligence with Gerard DeBenedetto
Chinese stock markets are susceptible to wild oscillations but the associated risks don’t always bring returns, even to the savvy investor. Investing in the fixed income market is one way to help balance the volatility.
China’s pharma companies are spending big on R&D, but global success remains elusive
Ambitious Chinese healthcare companies are using artificial intelligence and genetic science to develop new drugs. But there is no shortcut to the market when it comes to innovative medicines.
Why the U.S. and China might broker a deal on U.S. capital access
Despite mounting bilateral tensions, capital flows may be one area the U.S. and China can find common ground.